Inhibition of proteases activity in intestine needs a sustainable acidic environment rather than a transient

References

• Renukuntla J, Vadlapudi AD, Patel A, et al. Approaches for enhancing oral bioavailability of peptides and proteins. Int J Pharm. 2013;447:75–93.
   PubMed Web of Science ®Google Scholar
• Aggarwal AK, Gupta M. Solubility and solution stability studies of different amino acid prodrugs of bromhexine. Drug Dev Ind Pharm. 2012;38:1319–1327.
   PubMed Web of Science ®Google Scholar
• Hädrich G, Monteiro SO, Rodrigues MR, et al. Lipid-based nanocarrier for quercetin delivery: system characterization and molecular interactions studies. Drug Dev Ind Pharm. 2016;42:1165–1173.
   PubMed Web of Science ®Google Scholar
• de Sousa IP, Bernkop-Schnürch A. Pre-systemic metabolism of orally administered drugs and strategies to overcome it. J Control Release. 2014;192:301–309.
   PubMed Web of Science ®Google Scholar
• Langguth P, Merkle HP, Amidon GL. Oral absorption of peptides: the effect of absorption site and enzyme inhibition on the systemic availability of metkephamid. Pharm Res. 1994;11:528–535.
   PubMed Web of Science ®Google Scholar
• Yamamoto A, Taniguchi T, Rikyuu K, et al. Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats. Pharm Res. 1994;11:1496–1500.
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A. The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. J Control Release. 1998;52:1–16.
   PubMed Web of Science ®Google Scholar
• Reseland JE, Holm H, Jacobsen MB, et al. Proteinase inhibitors induce selective stimulation of human trypsin and chymotrypsin secretion. J Nutr 1996;126:634–642.
   PubMed Web of Science ®Google Scholar
• Schilling RJ, Mitra AK. Degradation of insulin by trypsin and alpha-chymotrypsin. Pharm Res. 1991;8:721–727.
   PubMed Web of Science ®Google Scholar
• Welling SH, Hubálek F, Jacobsen J, et al. The role of citric acid in oral peptide and protein formulations: relationship between calcium chelation and proteolysis inhibition. Eur J Pharm Biopharm. 2014;86:544–551.
   PubMed Web of Science ®Google Scholar
• Binkley N, Bolognese M, Sidorowicz-Bialynicka A, et al. A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial. J Bone Miner Res. 2012;27:1821–1829.
   PubMed Web of Science ®Google Scholar
• Bai JPF, Chang LL, Guo JH. Effects of polyacrylic polymers on the lumenal proteolysis of peptide drugs in the colon. J Pharm Sci. 1995;84:1291–1294.
   PubMed Web of Science ®Google Scholar
• Bai JPF, Chang LL, Guo JH. Effects of polyacrylic polymers on the degradation of insulin and peptide drugs by chymotrypsin and trypsin. J Pharm Pharmacol. 1996;48:17–21.
   PubMed Web of Science ®Google Scholar
• Lee HY, Sinko PJ. Oral delivery of salmon calcitonin. Adv Drug Deliv Rev. 2000;42:225–238.
   PubMed Web of Science ®Google Scholar
• Hummel BCW. A modified spectrophotometric determination of chymotrypsin, trypsin, and thrombin. Biochem Cell Biol. 1959;37:1393–1399.
   Google Scholar
• Arnon R. Papain. Methods Enzymol. 1970;19:226–244.
   Google Scholar
• Rowe RC, Sheskey PJ, Owen SC. Handbook of Pharmaceutical Excipients 2009;6:181–183.
   Google Scholar
• Slechtova T, Gilar M, Kalikova K, et al. Insight into trypsin miscleavage: comparison of kinetic constants of problematic peptide sequences. Anal Chem. 2015;87:7636–7643.
   PubMed Web of Science ®Google Scholar
• Chen YH, Yang JT, Chau KH. Determination of the helix and beta form of proteins in aqueous solution by circular dichroism. Biochemistry 1974;13:3350–3359.
   PubMed Web of Science ®Google Scholar
• Byler DM, Susi H. Examination of the secondary structure of proteins by deconvolved FTIR spectra. Biopolymers 1986;25:469–487.
   PubMed Web of Science ®Google Scholar
• Sinko PJ. Intestinal absorption of peptides and peptide analogues: Implications of fasting pancreatic serine protease levels and pH on the extent of oral absorption in dogs and humans. Pharm Res. 1992;9:320–325.
   PubMed Web of Science ®Google Scholar
• Murthy SNS, Kostman J, Dinoso VP. Jr, Effect of pH, substrate, and temperature on tryptic activity of duodenal samples. Dig Dis Sci. 1980;25:289–294.
   PubMed Web of Science ®Google Scholar
• Martinek K, Mozhaev VV, Smirnov MD, et al. Reactivation of “irreversibly” denaturated enzymes. Biotechnol Bioeng. 1980;22:247–251.
   PubMed Web of Science ®Google Scholar
• Kawano M, Kuwabara T. pH-dependent reversible inhibition of violaxanthin de-epoxidase by pepstatin related to protonation-induced structural change of the enzyme. FEBS Lett. 2000;481:101–104.
   PubMed Web of Science ®Google Scholar
• Prasad M, Thomas JL, Whittal RM, et al. Mitochondrial 3β-hydroxysteroid dehydrogenase enzyme activity requires reversible pH-dependent conformational change at the intermembrane space. J Biol Chem. 2012;287:9534–9546.
   PubMed Web of Science ®Google Scholar
• Sudharshan E, Srinivasulu S, Rao AGA. pH-induced domain interaction and conformational transitions of lipoxygenase-1. BBA-Protein Struct M. 2000;1480:13–22.
   PubMed Web of Science ®Google Scholar
• Martins NF, Ferreira E, Torres KC, et al. The denaturation of alpha, beta and psi bovine trypsin at pH 3.0: evidence of intermediates. Protein Pept Lett. 2003;10:73–81.
   PubMed Web of Science ®Google Scholar
• Markley JL, Westler WM. Protonation-state dependence of hydrogen bond strengths and exchange rates in a serine protease catalytic triad: bovine chymotrypsinogen A. Biochemistry 1996;35:11092–11097.
   PubMed Web of Science ®Google Scholar
• Shiraki K, Norioka S, Li S, et al. Electrostatic role of aromatic ring stacking in the pH-sensitive modulation of a chymotrypsin-type serine protease, achromobacter protease I. Eur J Biochem. 2002;269:4152–4158.
   PubMedGoogle Scholar
• Perdikis DA, Davies R, Zhuravkov A, et al. Differential effects of mucosal pH on human (Caco-2) intestinal epithelial cell motility, proliferation, and differentiation. Dig Dis Sci. 1998;43:1537–1546.
   PubMed Web of Science ®Google Scholar
• Swaid F, Sukhotnik I, Matter I, et al. Dietary glutamine supplementation prevents mucosal injury and modulates intestinal epithelial restitution following acetic acid induced intestinal injury in rats. Nutr Metab (Lond). 2013;10:1.
   PubMed Web of Science ®Google Scholar